Nottingham, UK (20 July 2009). Novozymes today announced that Geoffrey Francis, Chief Scientist at Novozymes Biopharma, has been named one of the 100 most inspiring people by PharmaVOICE magazine in recognition of his influence in the life science industry.
The PharmaVOICE 100 were nominated by PharmaVoice readers who identified the individuals they believe have the greatest influence and positive impact on corporate leadership, research and development, technology, creativity, marketing and business strategies.
"It's a great honor to have been recognized by my peers and to be profiled alongside such an esteemed group of industry leaders," commented Geoffrey Francis, Chief Scientist at Novozymes Biopharma and PharmaVOICE 100 honoree. "I am delighted that this honor validates Novozymes Biopharma's mission and is a real testament to the outstanding team we have here."
Geoffrey Francis' nomination and selection to the PharmaVOICE 100 was based on his exceptional 30 year career in the life sciences and biotechnology industries and his ability to inspire and motivate those around him. With specific expertise in drug discovery, protein expression, cell biology, animal physiology and protein biochemistry, Geoffrey has a long and successful career in senior management and research within government, academia and industry.
Determined to make a difference, Geoffrey used his expertise as part of the team to found the Cooperative Research Centre for Tissue Growth and Repair, Adelaide in 1991 and held senior scientist positions at CSIRO Human Nutrition and GroPep Ltd. before joining Novozymes Biopharma in 2006.
Based in Adelaide, Australia Geoffrey currently is a key member of a worldwide team of scientists and advises on scientific and industry issues in the area of biopharmaceutical drug development. Established five years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life sciences industry. The distinguished honorees are nominated by thousands of PharmaVOICE readers. The PharmaVOICE 100 are selected based on comprehensive essays describing how individuals inspired or motivated them or affected positive changes as well as other factors, such as community and philanthropic activities.
Editor-in-chief and co-founder of PharmaVOICE, Taren Grom, comments: "The PharmaVoice 100 are individuals who think outside the box, pioneer new paths to success, and inspire their colleagues in the industry; they translate industry issues into opportunities and take the time to mentor the next generation of leaders in the life sciences arena."
For further information on Novozymes Biopharma's products and technologies, please visit http://biopharma.novozymes.com.
About Novozymes
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes' bioinnovations improve industrial performance and safeguard the world's resources by offering superior and sustainable solutions for tomorrow's ever-changing marketplace.Novozymes' natural solutions enhance and promote everything from removing trans fats in cooking, to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature's potential is evidenced by over 6,000 patents, showing what is possible when nature and technology join forces. Our 5,000+ employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow.
The PharmaVOICE 100 were nominated by PharmaVoice readers who identified the individuals they believe have the greatest influence and positive impact on corporate leadership, research and development, technology, creativity, marketing and business strategies.
"It's a great honor to have been recognized by my peers and to be profiled alongside such an esteemed group of industry leaders," commented Geoffrey Francis, Chief Scientist at Novozymes Biopharma and PharmaVOICE 100 honoree. "I am delighted that this honor validates Novozymes Biopharma's mission and is a real testament to the outstanding team we have here."
Geoffrey Francis' nomination and selection to the PharmaVOICE 100 was based on his exceptional 30 year career in the life sciences and biotechnology industries and his ability to inspire and motivate those around him. With specific expertise in drug discovery, protein expression, cell biology, animal physiology and protein biochemistry, Geoffrey has a long and successful career in senior management and research within government, academia and industry.
Determined to make a difference, Geoffrey used his expertise as part of the team to found the Cooperative Research Centre for Tissue Growth and Repair, Adelaide in 1991 and held senior scientist positions at CSIRO Human Nutrition and GroPep Ltd. before joining Novozymes Biopharma in 2006.
Based in Adelaide, Australia Geoffrey currently is a key member of a worldwide team of scientists and advises on scientific and industry issues in the area of biopharmaceutical drug development. Established five years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life sciences industry. The distinguished honorees are nominated by thousands of PharmaVOICE readers. The PharmaVOICE 100 are selected based on comprehensive essays describing how individuals inspired or motivated them or affected positive changes as well as other factors, such as community and philanthropic activities.
Editor-in-chief and co-founder of PharmaVOICE, Taren Grom, comments: "The PharmaVoice 100 are individuals who think outside the box, pioneer new paths to success, and inspire their colleagues in the industry; they translate industry issues into opportunities and take the time to mentor the next generation of leaders in the life sciences arena."
For further information on Novozymes Biopharma's products and technologies, please visit http://biopharma.novozymes.com.
About Novozymes
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes' bioinnovations improve industrial performance and safeguard the world's resources by offering superior and sustainable solutions for tomorrow's ever-changing marketplace.Novozymes' natural solutions enhance and promote everything from removing trans fats in cooking, to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature's potential is evidenced by over 6,000 patents, showing what is possible when nature and technology join forces. Our 5,000+ employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow.
